Bio Tears Oral Gel Caps for Dry Eye, 120 count
BioSyntrx BioTears - 120 Gel Caps BioSyntrx BioTears contain the optimal blend of Omega 3 and Omega 6 essentials fatty acids, plus all the nutrient co-factors suggested in peer-reviewed clinical studies to enhance the metabolic conversion associated with the tear-specific series one anti-inflammatory prostaglandin, PGE1. BioSyntrx BioTears include nutrients that are suggested in peer-reviewed clinical studies to appropriately inhibit the essential fatty acid arachidonic acid production of the COX2 enzyme, the pro-inflammatory prostaglandin PGE2, and Interleukin Il-6. BioSyntrx BioTears include nutrients that are suggested to modulate goblet cell/mucin production in both the stimulated and unstimulated tear, the lacrimal gland aqueous output, as well as the meibomian gland oil output, which is vital to the prevention of evaporative dry eyes. The female led research team that invented BioTears opened the doors for nutritional therapy where dry eye is concerned in 1998. BioTears Oral GelCaps also contain APO-Lactoferrin, which is suggested to inhibit the growth of both viral and bacterial pathogens and biofilms in the three-layer tear film. BioSyntrx BioTears systemically address the root inflammatory cause and effects of dry eyes. BioSyntrx BioTears hassuggested in peer-reviewed literature that these specific nutrients support normal production of lubricants in other affected parts of the body, such as mucous membranes of the mouth and vagina, and interior body surfaces such as joints and synovial membranes. An intact tear film is necessary for optimal visual acuity.